Source: ERJ Open Res, 6 (1) 00130-2019; 10.1183/23120541.00130-2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Lihong Zhong, Ying Xiong, Zeguang Zheng, Ni Liu, Jieying Hu, Feng Yang, Rongchang Chen. Effect of short-term inhalation of warm saline atomised gas on patients with non-cystic fibrosis bronchiectasis. ERJ Open Res, 6 (1) 00130-2019; 10.1183/23120541.00130-2019

Member's Comments

No comment yet.

Related content which might interest you: The assesment of aerosol solution lung deposition in cystic fibrosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 584s Year: 2004 Health status impact of ciprofloxacin dry powder for inhalation in patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011 Evaluation of inhaled dry powder tobramycin free base in non-cystic fibrosis bronchiectasis patients Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Changes in lung gas mixing after physiotherapy in adults with cystic fibrosis Source: Annual Congress 2007 - Critical care and airways clearance Year: 2007 Effects of dornase alfa and hypertonic saline on gas mixing in lung periphery in children with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis Source: Eur Respir J 2003 Dec 01;22(6):972-979 Year: 2003 Nebulised 7 % hypertonic sodium chloride improves lung function and airway clearance in non cystic fibrosis bronchiectasis Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010 Efficacy and safety of ciprofloxacin dry powder for inhalation in patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2011 - Advances in antibiotic therapy of non-cystic fibrosis bronchiectasis Year: 2011 Effect of inhaled salt-bromide-iodine thermal water on airway inflammation in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 289s Year: 2004 Nebulised 7% hypertonic saline improves health related quality of life in patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2011 - Chest physiotherapy and breathing retraining Year: 2011 The efficacy and tolerability of inhaled hypertonic saline in children with cystic fibrosis Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020 Antimicrobial efficacy of ciprofloxacin dry powder for inhalation in patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2011 - Advances in antibiotic therapy of non-cystic fibrosis bronchiectasis Year: 2011 Nebulized saline treatment in patients with concomitant asthma and bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 Effects of oxygen inhalation during exercise in patients with combined pulmonary fibrosis and emphysema (CPFE) Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing Year: 2010 Control of the inhalation technique in cystic fibrosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 262s Year: 2006 Effect of azithromycin on FEV1 and exacerbation frequency in adult non-cystic fibrosis bronchiectasis Source: Eur Respir J 2007; 30: Suppl. 51, 528s Year: 2007 Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation Source: Eur Respir J 2011; 38: 1328-1335 Year: 2011 Effects of long-term azithromycin treatment in patients with non-cystic fibrosis stable bronchiectasis Source: Annual Congress 2007 - Infectious lung and pleural diseases Year: 2007 Breath condensate is acidified during infective exacerbations in children with cystic fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 527s Year: 2002 Effect of hypertonic saline on mucociliary clearance and clinical outcomes in chronic bronchitis Source: ERJ Open Res, 6 (3) 00269-2020; 10.1183/23120541.00269-2020 Year: 2020